Investor Presentation Q1 2018

Investor Presentation First three months of 2018 The GLP-1 segment accounts for around 1% of the total diabetes care market value in Region China Slide 70 GLP-1 value in bDKK China GLP-1 market VictozaⓇ exenatide Share of total diabetes care GLP-1 value VictozaⓇ value market share in China VictozaⓇ exenatide market share market 100% 0.20 2.0% CAGR value¹: 28.9% 0.15 80% 1.5% 72% 60% - 0.10 - 1.0% 40% 0.05 + 0.5% 27% 20% 0.00 Feb 2013 0.0% 0% Feb 2018 Feb 2013 Feb 2018 1 CAGR for 5-year period Source: IQVIA monthly MAT Feb, 2018 value figures (DKK) changing diabetes® Source: IQVIA monthly MAT Feb, 2018 value figures (DKK), market share does not add up to 100% due to rounding novo nordisk

View entire presentation